ProfessorRoderick Clifton-Bligh
Conjoint Associate Professor
Faculty of Medicine and Health
Orcid identifier0000-0002-1545-0368 (opens in a new tab)
- Conjoint Associate ProfessorFaculty of Medicine and Health
Research projects & supervision summary
- Role of FOXE1 in thyroid development and cancer
- Genomic landscape of phaeochromocytoma-paraganglioma
- Multiple Endocrine Neoplasia Type 1: developing new biomarkers for disease and targets for treatment.
- Endocrinopathies associated with immune checkpoint inhibitors
- Active surveillance for low risk thyroid cancers
- Tumour microenviroment in differentiated thyroid cancer: the role of thyroid autoimmunity.
- Randomized clinical trial investigating romosozumab with or without high intensity resistance training in post-menopausal osteoporosis.
Publications and Impact: 287 publications (106 in past 5 y, 11,758 total citations; H-score: 59; FWCI: 2.46) including 30.4% of publications in the top 10% most cited publications worldwide, 50.5% of publications in the top 10% journals by CiteScore.
Contribution to the field and impact: ranked in the top 0.061% of published authors worldwide on paraganglioma (Expertscape), in the top 0.3% on thyroid cancer and in the top 1.1% of authors on Multiple Endocrine Neoplasia. He is a member of the International Thyroid Oncology Group (which facilitates clinical trials in thyroid cancer), the A5 alliance (facilitating adrenal research in North and South America, Australia and Asia), and on the medical advisory board for the Pheo-Para Alliance (supporting patients with phaeochromocytomas and paragangliomas.)
RESEARCH PROJECTS & ACTIVITIES
- RESEARCH-BASED DEGREE SUPERVISIONElucidating the phenotype of immune checkpoint inhibitor related pituitary toxicity
- RESEARCH-BASED DEGREE SUPERVISIONFOXE1 and TERT: Developmental origins of Thyroid Cancer
- RESEARCH-BASED DEGREE SUPERVISIONFunctional Studies of the Genetic Alterations in Phaeochromocytomas and Paragangliomas
- RESEARCH-BASED DEGREE SUPERVISIONGenetic profiling of phaeochromocytoma and paraganglioma: towards precision medicine
- RESEARCH-BASED DEGREE SUPERVISIONHereditary phaeochromocytoma and paraganglioma in SDHB pathogenic variant carriers: clinical outcomes, surveillance strategies and economic evaluation
- RESEARCH-BASED DEGREE SUPERVISIONImmune Landscape in Thyroid Cancer
- RESEARCH-BASED DEGREE SUPERVISIONPersonalisation of Thyroid Cancer Management
- RESEARCH-BASED DEGREE SUPERVISIONPersonalised Medicine for Thyroid Cancer
- RESEARCH-BASED DEGREE SUPERVISIONRe-imagining osteoporosis treatment: innovative strategies to optimise the use of existing therapies
- RESEARCH-BASED DEGREE SUPERVISIONReprogramming the peritoneal immune microenvironment to restore antitumour immunity and control ascites formation in diffuse peritoneal disease
- RESEARCH-BASED DEGREE SUPERVISIONThe Australian Multiple Endocrine Neoplasia Type 1 (AusMEN1) Study
- RESEARCH-BASED DEGREE SUPERVISIONThyroid Immune Related Adverse Events Following Immune Checkpoint Inhibitor Treatment